Entrepreneur, Healthcare Commercialisation & Internationalisation Startup - SME Facilitator - Project Commercial Lead
NADMED Ltd.
NADMED has developed a metabolite extraction system that accurately measures all four NAD types and glutathione from blood samples using a colorimetric quantification method. This technology addresses the need for reliable and rapid testing methods in clinical and research settings, enhancing the understanding of NAD levels in relation to various metabolic and degenerative diseases.
- Biotechnology
Updated 23 months ago
Funding
Raised to date
$3.9MRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Problem
Current methods for measuring NAD (nicotinamide adenine dinucleotide) and glutathione levels often lack the accuracy, speed, and cost-effectiveness required for comprehensive clinical and research applications. Existing technologies may struggle to individually measure all four NAD types and glutathione from small blood samples, hindering the understanding of their roles in metabolic and degenerative diseases.
Solution
NADMED offers a metabolite extraction system and associated kits that accurately quantify all four NAD types (NAD+, NADH, NADP+, NADPH) and glutathione from blood and tissue/cell samples using a colorimetric quantification method. This technology provides clinical laboratories and researchers with a reliable, rapid, and cost-effective solution for measuring these key metabolites. The NADMED method allows for individual measurement of each metabolite, offering a distinct advantage over other methods. NADMED provides both CE-marked blood kits and RUO (Research Use Only) tissue/cell kits, as well as a laboratory service to support research and drug development.
Target Audience
NADMED's products and services target clinical laboratories needing accurate and reliable metabolite measurements, as well as researchers in the fields of metabolic and degenerative diseases, and pharmaceutical companies involved in drug development.
Features
- Colorimetric quantification method for accurate measurement of NAD+ and glutathione levels.
- Ability to measure all four NAD types (NAD+, NADH, NADP+, NADPH) individually.
- Minimal sample volume required, enabling measurements from small blood samples.
- Rapid testing process for quick turnaround times.
- CE-marked blood kits available for clinical use.
- RUO (Research Use Only) kits available for tissue and cell samples.
- Laboratory service offered for research and drug development support.